Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shahinaz Bedri, Ali A. Sultan, Moussa Alkhalaf, Ala-Eddin Al Moustafa & Semir Vranic. (2019) Epstein-Barr virus (EBV) status in colorectal cancer: a mini review. Human Vaccines & Immunotherapeutics 15:3, pages 603-610.
Read now
Read now
Articles from other publishers (18)
Fidel M Perez, Gladys L Valdez, Patrick WU, Moazzum Bajwa & Faheem Jukaku. (2023) A Rare Case of Primary Anorectal Hodgkin Lymphoma in an HIV-Positive Patient: A Case Report and Literature Review. Cureus.
Crossref
Crossref
Hui Zhang, Shuliang Zhao & Zhijun Cao. (2022) Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease. Frontiers in Immunology 13.
Crossref
Crossref
Shuang Wu, Chuan He, Tong-Yu Tang & Yu-Qin Li. (2019) A review on co-existent Epstein–Barr virus-induced complications in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 31:9, pages 1085-1091.
Crossref
Crossref
Shuji Momose & Jun-ichi Tamaru. (2019) Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting. Journal of Clinical and Experimental Hematopathology 59:2, pages 48-55.
Crossref
Crossref
Merav Barzilai, Aaron Polliack, Irit Avivi, Yair Herishanu, Ron Ram, Catherine Tang, Chava Perry & Nadav Sarid. (2018) Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: Portrait of a rare clinical entity. Leukemia Research 71, pages 1-5.
Crossref
Crossref
Periklis G Foukas & Laurence de Leval. (2015) Recent advances in intestinal lymphomas. Histopathology 66:1, pages 112-136.
Crossref
Crossref
K. Subramaniam, M. Cherian, S. Jain, M. Latimer, M. Corbett, J. D'Rozario & P. Pavli. (2013) Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications. Internal Medicine Journal 43:12, pages 1339-1342.
Crossref
Crossref
Tonya Adamiak, Dorota Walkiewicz-Jedrzejczak, Daryl Fish, Christopher Brown, Jeanne Tung, Khalid Khan, William FaubionJrJr, Roger Park, Janice Heikenen, Michael Yaffee, Maria T. Rivera-Bennett, Marcy Wiedkamp, Michael Stephens, Richard Noel, Melodee Nugent, Justin Nebel, Pippa Simpson, Michael D. Kappelman & Subra Kugathasan. (2013) Incidence, Clinical Characteristics, and Natural History of Pediatric IBD in Wisconsin. Inflammatory Bowel Diseases 19:6, pages 1218-1223.
Crossref
Crossref
Sebastian Bernardo, Sara Harcharik, Michael Pan, Brieze Keeley & Mark Lebwohl. (2018) Biologic Drugs and Malignancy: A Literature Review Examining the Impact of Concomitant Immunosuppressive Medications. Psoriasis Forum 18a:4, pages 152-163.
Crossref
Crossref
Konstantinos H. Katsanos, Athina Tatsioni, Natalia Pedersen, Mary Shuhaibar, Vicent Hernandez Ramirez, Patrizia Politi, Evelien Rombrechts, Marieke Pierik, Juan Clofent, Marina Beltrami, Paolo Bodini, Joao Freitas, Ioannis Mouzas, Giovanni Fornaciari, Bjorn Moum, Peter Laszlo Lakatos, Severine Vermeire, Ebbe Langholz, Selwyn Odes, Colm O'. Morain, Reinhold Stockbrügger, Pia Munkholm & Epameinondas V. Tsianos. (2011) Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study. Journal of Crohn's and Colitis 5:5, pages 430-442.
Crossref
Crossref
Hélène Théophile, Thierry Schaeverbeke, Ghada Miremont-Salamé, Abdelilah Abouelfath, Valentine Kahn, Françoise Haramburu & Bernard Bégaud. (2011) Sources of Information on Lymphoma Associated with Anti-Tumour Necrosis Factor Agents. Drug Safety 34:7, pages 577-585.
Crossref
Crossref
Ryan D. Cassaday, Jeffrey T. Malik & Julie E. Chang. (2011) Regression of Hodgkin Lymphoma After Discontinuation of a Tumor Necrosis Factor Inhibitor for Crohn's Disease: A Case Report and Review of the Literature. Clinical Lymphoma Myeloma and Leukemia 11:3, pages 289-292.
Crossref
Crossref
Gulbanu Erkan, Mehmet Çoban, Aysun Çalıskan, Gokçe Kaan Ataç, Kamil Gulpınar, Bulent Degertekin & Atilla Korkmaz. (2011) A Burkitt's Lymphoma Case Mimicking Crohn's Disease: A Case Report. Case Reports in Medicine 2011, pages 1-4.
Crossref
Crossref
W. Miehsler, G. Novacek, H. Wenzl, H. Vogelsang, P. Knoflach, A. Kaser, C. Dejaco, W. Petritsch, M. Kapitan, H. Maier, W. Graninger, H. Tilg & W. Reinisch. (2010) A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. Journal of Crohn's and Colitis 4:3, pages 221-256.
Crossref
Crossref
Nicola Petrosillo & Cecilia M. J. Drapeau. 2010. Crohn’s Disease. Crohn’s Disease
239
248
.
J.F. Rahier, S. Ben-Horin, Y. Chowers, C. Conlon, P. De Munter, G. D'Haens, E. Domènech, R. Eliakim, A. Eser, J. Frater, M. Gassull, M. Giladi, A. Kaser, M. Lémann, T. Moreels, A. Moschen, R. Pollok, W. Reinisch, M. Schunter, E.F. Stange, H. Tilg, G. Van Assche, N. Viget, B. Vucelic, A. Walsh, G. Weiss, Y. Yazdanpanah, Y. Zabana, S.P.L. Travis & J.F. Colombel. (2009) European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn's and Colitis 3:2, pages 47-91.
Crossref
Crossref
Anh T. Nguyen, Shahreyar Hashemi, Michael R. Castellano, Michael Eisenbraun & Gene F. Coppa. (2009) A New Subtype of Hodgkin’s Lymphoma, Syncytial Nodular Sclerosing: First Case Report of Primary Small Bowel Lymphoma. Journal of Gastrointestinal Cancer 40:1-2, pages 38-40.
Crossref
Crossref
Athanasios A. Papathanasopoulos, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Spyridon Nikas & Epameinondas V. Tsianos. (2007) An unusual case of Crohn's disease with unresponsive pleural exudates. Is Crohn's disease finally a systemic immunological disorder?. Journal of Crohn's and Colitis 1:2, pages 116-121.
Crossref
Crossref